Nautilus Biotechnology

(NASDAQ) NAUT

Current Price$2.63

Market Cap$374.88M

Since IPO (2020)-72%

5 YearN/A

1 Year+197%

1 Month-14%

Nautilus Biotechnology Financials at a Glance

Market Cap

$374.88M

Revenue (TTM)

$0.00

Net Income (TTM)

$57.09M

EPS (TTM)

$-0.45

P/E Ratio

-6.53

Dividend

$0.00

Beta (Volatility)

1.67 (High)

Dividend

$0.00

Beta (Volatility)

1.67 (High)

Price

$2.63

Volume

33,524

Open

$2.90

Price

$2.63

Volume

33,524

Open

$2.90

Previous Close

$2.63

Daily Range

$2.55 - $2.90

52-Week Range

$0.62 - $4.31

Dividend

$0.00

Beta (Volatility)

1.67 (High)

Price

$2.63

Volume

33,524

Open

$2.90

Previous Close

$2.63

Daily Range

$2.55 - $2.90

52-Week Range

$0.62 - $4.31

NAUT News

No articles available.

NAUT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nautilus Biotechnology

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

130

CEO

Sujal M. Patel

Website

www.nautilus.bio

Headquarters

Seattle, WA 98102, US

NAUT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-34%

Return on Capital

-38%

Return on Assets

-32%

Earnings Yield

-15.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$374.88M

Shares Outstanding

127.08M

Volume

33.52K

Avg. Volume

335.68K

Financials (TTM)

Gross Profit

$6.46M

Operating Income

$66.84M

EBITDA

$52.54M

Operating Cash Flow

$50.70M

Capital Expenditure

$1.28M

Free Cash Flow

$51.97M

Cash & ST Invst.

$103.41M

Total Debt

$30.02M

Nautilus Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$1.48M

N/A

Gross Margin

0.00%

N/A

Market Cap

$374.88M

N/A

Market Cap/Employee

$2.80M

N/A

Employees

134

N/A

Net Income

$14.70M

+11.5%

EBITDA

$14.65M

+14.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$67.00M

-38.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$25.02M

-0.3%

Short Term Debt

$3.85M

-9.2%

Return on Assets

-32.11%

N/A

Return on Invested Capital

-37.84%

N/A

Free Cash Flow

$13.61M

+3.9%

Operating Cash Flow

$13.10M

+6.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ENTAEnanta Pharmaceuticals, Inc.

ENTAEnanta Pharmaceuticals, Inc.$13.81-1.57%

ZURAZura Bio Limited

ZURAZura Bio Limited$4.83+0.63%

ASMBAssembly Biosciences, Inc.

ASMBAssembly Biosciences, Inc.$30.30-4.48%

SGMTSagimet Biosciences Inc.

SGMTSagimet Biosciences Inc.$7.37-3.03%

FHTXFoghorn Therapeutics Inc.

FHTXFoghorn Therapeutics Inc.$4.04-3.12%

ARCTArcturus Therapeutics Holdings Inc.

ARCTArcturus Therapeutics Holdings Inc.$7.83-5.21%

IMRXImmuneering Corporation

IMRXImmuneering Corporation$5.14-4.46%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

FFord Motor Company

FFord Motor Company$14.48+0.07%

AIIORobo.ai

AIIORobo.ai$5.64+1.16%

NOKNokia

NOKNokia$14.46-0.02%

INTCIntel

INTCIntel$115.93-0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.65-0.01%

AALAmerican Airlines Group

AALAmerican Airlines Group$12.70-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$78.95+0.02%

Questions About NAUT

What is the current price of Nautilus Biotechnology?

Nautilus Biotechnology is trading at $2.63 per share.

What is the 52-week range for Nautilus Biotechnology?

Over the past 52 weeks, Nautilus Biotechnology has traded between $0.62 and $4.31.

How much debt does Nautilus Biotechnology have?

As of the most recent reporting period, Nautilus Biotechnology reported total debt of $28.87M.

How much cash does Nautilus Biotechnology have on hand?

Nautilus Biotechnology reported $14.63M in cash and cash equivalents in its most recent financial results.

What is Nautilus Biotechnology’s dividend yield?

Nautilus Biotechnology does not currently have a dividend yield.

Nautilus Biotechnology

Nautilus Biotechnology Financials at a Glance

NAUT News

NAUT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nautilus Biotechnology

NAUT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nautilus Biotechnology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NAUT

What is the current price of Nautilus Biotechnology?

What is the 52-week range for Nautilus Biotechnology?

How much debt does Nautilus Biotechnology have?

How much cash does Nautilus Biotechnology have on hand?

What is Nautilus Biotechnology’s dividend yield?

Premium Investing Services